Laboratory tests in diagnosis and management of diabetes mellitus. Practical considerations

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 9, 2003, Pages 1259-1265

  Miedema, Kor ^a  

^a Clinical Laboratory   (Netherlands)

Author keywords

Diabetes mellitus; Disease management; Glucose HbA1c; Laboratory management; Microalbuminuria

Indexed keywords

3 HYDROXYBUTYRIC ACID; ALBUMIN; C PEPTIDE; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; KETONE; LIPID; PROINSULIN;

ANALYTIC METHOD; CLINICAL LABORATORY; DIABETES MELLITUS; GENETIC ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOASSAY; KIDNEY FUNCTION TEST; LABORATORY DIAGNOSIS; LABORATORY TEST; LIPID ANALYSIS; MEDICAL DECISION MAKING; METABOLIC REGULATION; MICROALBUMINURIA; ORAL GLUCOSE TOLERANCE TEST; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SELF EXAMINATION;

ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; C-REACTIVE PROTEIN; CLINICAL LABORATORY TECHNIQUES; DIABETES MELLITUS; GENETIC MARKERS; GLUCOSE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; INSULIN; KIDNEY FUNCTION TESTS; LIPIDS; MASS SCREENING;

EID: 0142124810     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.193     Document Type: Review

References (31)

1. ADA. Clinical Practice Recommendations 2003. Diabetes Care 2003 26:Suppl 1:S1-S156.
2. Sachs DB, Bruns DE, Goldstein DE, MacLaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48:436-72.
3. John WG, editor. Monitoring glycaemic control in the diabetic patient. London: Elsevier Science Ltd, 2002:207 pp.
4. ADA. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183-1201.
5. WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: World Health Organisation, 1999.
6. Lamb EJ, Day AP. New diagnostic criteria for diabetes mellitus: are we any further forward? Ann Clin Biochem 2000; 37:582-92.
7. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab 1999; 59:491-500.
8. Haeckel R, Brinck U, Ciloc D, Janka H-W, Püntmann I, Schneider J, Viebrock C. Comparability of blood glucose concentrations measured in different sample systems for detecting glucose intolerance. Clin Chem 2002; 48:936-9.
9. Kuwa K, Nakayama T, Hoshino T, Tominaga M. Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clin Chim Acta 2001; 307:187-92.
10. IFCC SD Working Group on selective electrodes. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta 2001; 307:205-9.
11. Chan AYW, Swaminathan R, Cockram CS. Efectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989; 35:315-7.
12. Andersson DKG, Svardsudd K. Long-term glycemic control relates to mortality in type 2 diabetes. Diabetes Care 1995; 18:1534-43.
13. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Diabet Med 1998; 15:539-53.
14. Metzger BE, Contan DR. Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care 1998; 21:B161-7.
15. Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB, Ferrara A, Liu J, Selb JV. Selfmonitoring of blood glucose levels and glycemic control. The Northern California Kaiser Permanente Diabetes Registry. Am J Med 2001; 111:1 -9.
16. Plessis du M, Ubbink JB, Vermaak WJH. Analytical quality of near-patient blood cholesterol and glucose measurement. Clin Chem 200; 46:1085-90.
17. Skeie S, Thue G, Nerhus K, Sandberg S. Instruments for self-monitoring of blood glucose: comparison of testing quality achieved by patients and a technician. Clin Chem 2002; 48:994-1003.
18. Jungheim K, Kochinsky T. Glucose monitoring on the arm. Risky delays of hypoglycemia and hyperglycemia detection. Diabetes Care 2002 ;25:956-60.
19. Porter WH, Yao HH, Karounos DG. Laboratory and clinical evaluation of assays for beta-hydroxybutyrate. Am J Clin Pathol 1997; 107:353-8.
20. Hoelzel W, Miedema K. Development of a reference system for the international standardisation of HbA1c/glycohemoglobin determinations. J Int Fed Clin Chem 1996; 9:62-7.
21. Hoelzel W, Weykamp C, Jeppsson J-O, Miedema K, Barr JR, Goodall I, et al. The IFCC reference system for the measurement of HbA1c in blood and the national standardization schemes in the USA, Japan and Sweden - a method comparison study. Clin Chem 2003; accepted for publication.
22. Mogensen CE, Vestbo E, Poulsen PL. Microalbuminuria and potential confounders: a review and some observations on variability of urinary albumin excretion. Diabetes Care 1995; 18:572-81.
23. Bakker AJ. Detection of microalbuminuria: receiver operating characteristics curve analysis favors albumin-to-creatinin over albumin excretion. Diabetes Care 1999; 22:307-13.
24. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel of detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285:2486-97.
25. Hawa MI, Beyan H, Buckley LR, Leslie RDG. Impact of genetic and non-genetic factors in type 1 diabetes. Am J Med Genet 2002; 115:8-17.
26. Elbein SC. Perspective: the search for genes for type 2 diabetes in the post genome era. Endocrinology 2002; 143: 2012-8.
27. Winter WE, Signorio MR, editors. Diabetes Mellitus. Washington: AACC Press, 2002:115.
28. Batstra MR, Aanstoot HJ, Herbrink P. Prediction and diagnosis of type 1 diabetes using β-cell autoantibodies. Clin Lab 2001; 47:497-507.
29. Faber OK, Binder CC. C-peptide: an index of insulin secretion. Diabetes Metab Rev 1986; 2:331-45.
30. Robbins DC, Andersen L, Bowsher R, Chance R, Dinensen B, Frank B, et al. Report of the American Diabetes Association's task force on standardisation of the insulin assay. Diabetes 1996; 45:242-56.
31. Morrow DA, Ridker PM. C-reactive protein, inflammation and coronary risk. Med Clin North Am 2000; 84:149-61.